| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 8 3688-3693, Copyright © 1996 by American Association of Immunologists
ARTICLES |
TW Kay, JL Parker, LA Stephens, HE Thomas and J Allison
Burnet Clinical Research Unit, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.
Beta2m-deficient nonobese diabetic (NODbeta2mnull) do not develop insulitis or diabetes. Expression of a beta2m transgene controlled by the rat insulin promoter (RIP-beta2m) in NODbeta2mnull mice resulted in reconstitution of IFN-gamma-inducible cell surface MHC class I protein on pancreatic beta-cells. These mice developed insulitis, but did not develop diabetes. Transfer of T cells from diabetic NOD mice to NODbeta2mnull recipients resulted in insulitis, which took several months to progress to diabetes. In contrast, transgenic RIP- beta2m/NODbeta2mnull mice with islet MHC class I reconstitution developed diabetes rapidly after transfer of diabetic NOD spleen cells. Administration of cyclophosphamide, which accelerates diabetes in NOD mice, resulted in 43% of RIPbeta2m/NODbeta2mnull mice becoming diabetic compared with 75% of wild-type mice and 0% of NODbeta2mnull mice. Acceleration of diabetes by cyclophosphamide was prevented by anti-CD8 mAb treatment. FACS analysis of peripheral blood and lymphoid organs from transgene-bearing animals did not show an increase in the number of CD8+ T cells compared with that in NODbeta2mnull mice. In summary, beta-cell expression of beta2m in NODbeta2mnull mice resulted in a return of insulitis, but not spontaneous diabetes. These studies demonstrate that beta2m and cell surface MHC class I expression on beta- cells are essential for the initiation of diabetes in the NOD mouse and further confirm that efficient progression to diabetes requires both CD4+ and CD8+ T cells.
This article has been cited by other articles:
|
|
 |
|
  H. Tsui, Y. Chan, L. Tang, S. Winer, R. K. Cheung, G. Paltser, T. Selvanantham, A. R. Elford, J. R. Ellis, D. J. Becker, et al. Targeting of Pancreatic Glia in Type 1 Diabetes Diabetes, April 1, 2008; 57(4): 918 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. de Jersey, S. L. Snelgrove, S. E. Palmer, S. A. Teteris, A. Mullbacher, J. F. A. P. Miller, and R. M. Slattery beta Cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice PNAS, January 23, 2007; 104(4): 1295 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Dudek, H. E. Thomas, L. Mariana, R. M. Sutherland, J. Allison, E. Estella, E. Angstetra, J. A. Trapani, P. Santamaria, A. M. Lew, et al. Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy {beta}-Cells via the Perforin and Fas Pathways Diabetes, September 1, 2006; 55(9): 2412 - 2418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Griseri, L. Beaudoin, J. Novak, L. T. Mars, F. Lepault, R. Liblau, and A. Lehuen Invariant NKT Cells Exacerbate Type 1 Diabetes Induced by CD8 T Cells J. Immunol., August 15, 2005; 175(4): 2091 - 2101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Toma, S. Haddouk, J.-P. Briand, L. Camoin, H. Gahery, F. Connan, D. Dubois-Laforgue, S. Caillat-Zucman, J.-G. Guillet, J.-C. Carel, et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients PNAS, July 26, 2005; 102(30): 10581 - 10586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics J. Immunol., March 1, 2005; 174(5): 2746 - 2755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yang, S. Hussain, Q.-S. Mi, P. Santamaria, and T. L. Delovitch Perturbed Homeostasis of Peripheral T Cells Elicits Decreased Susceptibility to Anti-CD3-Induced Apoptosis in Prediabetic Nonobese Diabetic Mice J. Immunol., October 1, 2004; 173(7): 4407 - 4416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Y. Arnold, A. R. Burton, and D. A. A. Vignali Diabetes Incidence Is Unaltered in Glutamate Decarboxylase 65-Specific TCR Retrogenic Nonobese Diabetic Mice: Generation by Retroviral-Mediated Stem Cell Gene Transfer J. Immunol., September 1, 2004; 173(5): 3103 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. W. Chong, Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. H. Kay, and H. E. Thomas Suppressor of Cytokine Signaling-1 Overexpression Protects Pancreatic {beta} Cells from CD8+ T Cell-Mediated Autoimmune Destruction J. Immunol., May 1, 2004; 172(9): 5714 - 5721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gurlo and H. v. Grafenstein Antigen-independent cross-talk between macrophages and CD8+ T cells facilitates their cooperation during target destruction Int. Immunol., September 1, 2003; 15(9): 1063 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. V. Parekh, D. V. R. Prasad, P. P. Banerjee, B. N. Joshi, A. Kumar, and G. C. Mishra B Cells Activated by Lipopolysaccharide, But Not By Anti-Ig and Anti-CD40 Antibody, Induce Anergy in CD8+ T Cells: Role of TGF-{beta}1 J. Immunol., June 15, 2003; 170(12): 5897 - 5911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Catterall, D. Stockwell, V. Marshall, A. Strasser, and J. Allison Autoimmune kidney disease and lymphadenopathy in NODlpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or {beta}2-microglobulin Int. Immunol., June 1, 2003; 15(6): 679 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Hamilton-Williams, S. E. Palmer, B. Charlton, and R. M. Slattery Beta cell MHC class I is a late requirement for diabetes PNAS, May 27, 2003; 100(11): 6688 - 6693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Wong, A. K. Moustakas, L. Wen, G. K. Papadopoulos, and C. A. Janeway Jr. Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2Kd that stimulates CD8 T cells in insulin-dependent diabetes mellitus PNAS, April 16, 2002; 99(8): 5551 - 5556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Kostek, J. A. Dominov, and J. B. Miller Up-Regulation of MHC Class I Expression Accompanies but Is Not Required for Spontaneous Myopathy in Dysferlin-Deficient SJL/J Mice Am. J. Pathol., March 1, 2002; 160(3): 833 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bercovici, A. Heurtier, C. Vizler, N. Pardigon, C. Cambouris, P. Desreumaux, and R. Liblau Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage J. Immunol., July 1, 2000; 165(1): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Green, F. S. Wong, K. Eshima, C. Mora, and R. A. Flavell Neonatal Tumor Necrosis Factor {alpha} Promotes Diabetes in Nonobese Diabetic Mice by CD154-independent Antigen Presentation to CD8+ T Cells J. Exp. Med., January 17, 2000; 191(2): 225 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Anderson, B.-J. Park, J. Verdaguer, A. Amrani, and P. Santamaria Prevalent CD8+ T cell response against one peptide/MHC complex in autoimmune diabetes PNAS, August 3, 1999; 96(16): 9311 - 9316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Thomas, R. Darwiche, J. A. Corbett, and T. W. H. Kay Evidence That {beta} Cell Death in the Nonobese Diabetic Mouse Is Fas Independent J. Immunol., August 1, 1999; 163(3): 1562 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Stephens, H. E. Thomas, L. Ming, M. Grell RIMA DARWICHE, L. Volodin, and T. W. H. Kay Tumor Necrosis Factor-{alpha}-Activated Cell Death Pathways in NIT-1 Insulinoma Cells and Primary Pancreatic {beta} Cells Endocrinology, July 1, 1999; 140(7): 3219 - 3227. [Abstract] [Full Text]
|
|
|
|
|
|
C. Mora, F. S. Wong, C.-H. Chang, and R. A. Flavell Pancreatic Infiltration But Not Diabetes Occurs in the Relative Absence of MHC Class II-Restricted CD4 T Cells: Studies Using NOD/CIITA-Deficient Mice J. Immunol., April 15, 1999; 162(8): 4576 - 4588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Susan Wong, I. Visintin, L. Wen, J. Granata, R. Flavell, and C. A. Janeway Jr. The Role of Lymphocyte Subsets in Accelerated Diabetes in Nonobese Diabetic-Rat Insulin Promoter-B7-1 (NOD-RIP-B7-1) Mice J. Exp. Med., June 15, 1998; 187(12): 1985 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wang, I. Andre, A. Gonzalez, J. D. Katz, M. Aguet, C. Benoist, and D. Mathis Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes PNAS, December 9, 1997; 94(25): 13844 - 13849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Wong, A. K. Moustakas, L. Wen, G. K. Papadopoulos, and C. A. Janeway Jr. Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2Kd that stimulates CD8 T cells in insulin-dependent diabetes mellitus PNAS, April 16, 2002; 99(8): 5551 - 5556. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
